The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through the Brazilian Unified Health System (SUS) over a 16-year period, between 2008 and 2023. Published in the Journal of Global Oncology (JCO), the official journal of the American Society of Clinical Oncology (ASCO), the study included researchers from the D’Or Institute for Research and Education (IDOR) and investigated patterns of diagnosis, treatment, and healthcare costs related to the disease across the country. The results revealed significant racial inequalities, including a higher frequency of advanced disease at diagnosis among non-white men and differences in therapeutic investment.

A scientific review published today in the NEJM Evidence journal, coordinated by the D’Or Institute for Research and Education (IDOR), evaluated outcomes of adults with community-acquired pneumonia (CAP) admitted to intensive care units (ICUs) in middle-income countries.

In contrast to high-income countries, where mortality ranges from 16% to 26%, the study found significantly higher rates in the countries analyzed. The work brought together 52 studies and approximately 48,707 patients, revealing an overall mortality rate of 37.1%, which increased to 59.3% among patients requiring respiratory support.